| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -1.1 | 0.09 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.49 | 0.005 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.32 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.31 | 3e-17 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.28 | 5e-07 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.27 | 0.0001 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.26 | 0.0004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.25 | 3e-13 |